Implementation and analysis of Babesia immunoassay testing

Lifelong withdrawal from the donor population of those who have been diagnosed with babesiosis must be used for transmission prevention. The aim of the study was a detection of Babesia antibodies level with the usage of experimental Babesia divergens whole-cell slide antigen and commercial B. microti immunofluorescence assay substrate slide (Fuller Laboratories, USA). Methods. Experimental B. divergens whole-cell slide antigen in addition to commercial B. microti IFA substrate slide was used to create a diagnostic kit for serum Babesia antibodies level detecting, as well as for a babesiosis serodiagnosis clinical trial of different origins blood samples (patients with Lyme disease, rheumatoid arthritis and toxoplasmosis; human blood donors; cattle). Results. Antibodies to B. divergens (5.4%) and B. microti (2.3%) were detected with higher (p